{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:49:26Z","timestamp":1791571766961,"version":"4.3.4"},"reference-count":204,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clindermatol.2026.07.026","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:18:49Z","timestamp":1785194329000},"page":"704-722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neutrophilic dermatoses"],"prefix":"10.1016","volume":"44","author":[{"given":"Emiley","family":"Vrooman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Grant-Kels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2026.07.026_bib0001","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13671-022-00355-8","article-title":"Neutrophilic dermatoses: a clinical update","volume":"11","author":"Weiss","year":"2022","journal-title":"Curr Dermatol Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0002","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jaad.2017.11.064","article-title":"Neutrophilic dermatoses: pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Beh\u00e7et disease","volume":"79","author":"Nelson","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0003","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3389\/fimmu.2019.00414","article-title":"Insights into the pathogenesis of Sweet\u2019s syndrome","volume":"10","author":"Heath","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0004","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","article-title":"Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases","volume":"162","author":"Marzano","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0190-9622(98)70266-X","article-title":"Sweet\u2019s syndrome: is the pathogenesis mediated by helper T cell type 1 cytokines?","volume":"39","author":"Giasuddin","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0006","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1993.tb03083.x","article-title":"Sweet\u2019s syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease","volume":"84","author":"Reuss-Borst","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0007","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/bjd.15105","article-title":"Are neutrophilic dermatoses autoinflammatory disorders?","volume":"178","author":"Satoh","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0008","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-020-0213-x","volume":"6","author":"Maverakis","year":"2020","journal-title":"Pyoderma gangrenosum. Nat Rev Dis Primer"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0009","first-page":"1639","article-title":"Dysregulated CARD9 signaling in neutrophils drives inflammation in a mouse model of neutrophilic dermatoses","volume":"201","author":"Tartey","year":"2018","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0010","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0560.2006.00654.x","article-title":"Clonality in the setting of Sweet\u2019s syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease","volume":"34","author":"Magro","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0011","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/jid.2012.408","article-title":"Evidence of Differentiation in Myeloid Malignancies Associated Neutrophilic Dermatosis: A Fluorescent In Situ Hybridization Study of 14 Patients","volume":"133","author":"Sujobert","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0012","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.jid.2019.12.040","article-title":"Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet\u2019s Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils","volume":"140","author":"Passet","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0013","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0190-9622(94)70026-5","article-title":"Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retnoic acid therapy","volume":"30","author":"Piette","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cancergen.2018.04.120","article-title":"Clonal neutrophil infiltrates in concurrent Sweet\u2019s syndrome and acute myeloid leukemia: a case report and literature review","volume":"226-227","author":"Mo","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood-2013-01-478172","article-title":"FLT3 inhibitor-induced neutrophilic dermatosis","volume":"122","author":"Fathi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0016","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamadermatol.2015.6121","article-title":"FLT3 inhibitor\u2013associated neutrophilic dermatoses","volume":"152","author":"Varadarajan","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0017","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archderm.1988.01670070057019","article-title":"Human leukocyte antigen in Sweet\u2019s syndrome and its relationship to Beh\u00e7et\u2019s disease","volume":"124","author":"Mizoguchi","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0018","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-4632.2009.04422.x","article-title":"Neutrophilic dermatosis of the dorsal hands: a case showing HLA B54, the marker of Sweet\u2019s syndrome","volume":"49","author":"Takahama","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0019","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0020","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 Variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ad.2015.12.001","article-title":"Sweet Syndrome: A Review and Update","volume":"107","author":"Villarreal-Villarreal","year":"2016","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0022","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/ckj\/sft134","article-title":"Azathioprine-induced Sweet syndrome in ANCA-associated vasculitis","volume":"6","author":"Neild","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0023","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1200\/JCO.1988.6.12.1887","article-title":"Malignancy-associated Sweet\u2019s syndrome: review of the world literature","volume":"6","author":"Cohen","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.critrevonc.2012.09.005","article-title":"Sweet\u2019s syndrome: A revisit for hematologists and oncologists","volume":"86","author":"Paydas","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","article-title":"Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients","volume":"69","author":"Rochet","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0026","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.1997.tb03796.x","article-title":"Sweet\u2019s syndrome and malignancy in the U.K","volume":"137","author":"Bourke","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0027","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2133.2006.07677.x","article-title":"Sweet\u2019s syndrome: a spectrum of unusual clinical presentations and associations","volume":"156","author":"Neoh","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0028","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/ced.12899","article-title":"Sweet syndrome: long-term follow-up of 138 patients","volume":"41","author":"Marcoval","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0029","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003033","article-title":"Histiocytoid Sweet syndrome is more frequently associated with myelodysplastic syndromes than the classical neutrophilic variant: a comparative series of 62 patients","volume":"95","author":"Ghoufi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0190-9622(94)70215-2","article-title":"Sweet\u2019s syndrome (acute febrile neutrophilic dermatosis)","volume":"31","author":"von den Driesch","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0031","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaad.2014.09.025","article-title":"Histiocytoid Sweet syndrome is infiltrated predominantly by M2-like macrophages","volume":"72","author":"Peroni","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0032","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1590\/abd1806-4841.20164361","article-title":"Histiocytoid Sweet\u2019s syndrome presenting with annular erythematous plaques","volume":"91","author":"Marcarini","year":"2016","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0033","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaad.2019.08.070","article-title":"Neutrophilic dermatosis of the dorsal hands: A review of 123 cases","volume":"88","author":"Micallef","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0034","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1067\/mjd.2000.109286","article-title":"Neutrophilic dermatosis of the dorsal hands: Pustular vasculitis revisited","volume":"43","author":"Galaria","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/1346-8138.15312","article-title":"Efficacy of acitretin in the treatment of reactive neutrophilic dermatoses in adult-onset immunodeficiency due to interferon-gamma autoantibody","volume":"47","author":"Rujiwetpongstorn","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0036","series-title":"StatPearls","article-title":"Sweet syndrome","author":"Vashisht","year":"2024"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0037","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40257-022-00673-4","article-title":"New practical aspects of sweet syndrome","volume":"23","author":"Joshi","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0038","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0190-9622(97)80222-8","article-title":"Indomethacin treatment of eighteen patients with Sweet\u2019s syndrome","volume":"36","author":"Jeanfils","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0039","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000326112","article-title":"Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret\u00ae) in a case of refractory Sweet\u2019s syndrome","volume":"222","author":"Kluger","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ecco-jcc\/jjy018","article-title":"Infliximab as rescue treatment in Sweet\u2019s syndrome related to corticodependent ulcerative colitis","volume":"12","author":"Moreno M\u00e1rquez","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0041","first-page":"122","article-title":"Recalcitrant Sweet syndrome successfully treated with adalimumab","volume":"19","author":"Calabrese","year":"2021","journal-title":"JDDG J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0042","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.080698","article-title":"Etanercept treatment in Sweet\u2019s syndrome with inflammatory arthritis","volume":"36","author":"Ambrose","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0043","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jaad.2005.11.1089","article-title":"Treatment of recurrent Sweet\u2019s syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept","volume":"54","author":"Yamauchi","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0044","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/08998280.2018.1460132","article-title":"Histiocytoid Sweet syndrome successfully treated with etanercept","volume":"31","author":"Watson","year":"2018","journal-title":"Proc Bayl Univ Med Cent"},{"key":"10.1016\/j.clindermatol.2026.07.026_sbref0045","series-title":"StatPearls","article-title":"Etanercept","author":"Pan","year":"2024"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0046","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1744-9987.12113","article-title":"Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy","volume":"17","author":"Sakanoue","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0047","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000475878","article-title":"Sweet\u2019s syndrome successfully treated with granulocyte and monocyte adsorption apheresis","volume":"9","author":"Fujii","year":"2017","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0048","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00128071-200203020-00005","article-title":"Sweet\u2019s syndrome: a review of current treatment options","volume":"3","author":"Cohen","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0049","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: a comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0050","article-title":"Narrative review: pyoderma gangrenosum","volume":"16","author":"Park","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0051","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jaad.2019.09.032","article-title":"Pyoderma gangrenosum in hematologic malignancies: A systematic review","volume":"82","author":"Montagnon","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0052","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-2008","article-title":"Effective strategies for the management of pyoderma gangrenosum: a comprehensive review","volume":"95","author":"Patel","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0053","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum \u2013 a guide to diagnosis and management","volume":"19","author":"George","year":"2019","journal-title":"Clin Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0054","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4103\/ijd.ijd_1133_20","article-title":"Pure bullous pyoderma gangrenosum, a challenging clinico-pathological diagnosis: critical literature review with emphasis on diagnostic criteria","volume":"67","author":"Garc\u00eda-Abell\u00e1s","year":"2022","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12016-010-8248-5","article-title":"The etiology of paraneoplastic autoimmunity","volume":"42","author":"Maverakis","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228772","article-title":"A case of bullous pyoderma gangrenosum","volume":"12","author":"Suvirya","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0057","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14954","article-title":"What can inherited immunodeficiencies reveal about pyoderma gangrenosum?","volume":"33","author":"Oprea","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0058","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s10875-014-0077-5","article-title":"Atypical severe combined immunodeficiency caused by a novel homozygous mutation in Rag1 gene in a girl who presented with pyoderma gangrenosum: a case report and literature review","volume":"34","author":"Patiroglu","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0059","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5114\/pdia.2013.35622","article-title":"Pyoderma gangrenosum in a patient with common variable primary immunodeficiency","volume":"30","author":"Bergler-Czop","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0060","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/bjd.12431","article-title":"Familial pyoderma gangrenosum in association with common variable immunodeficiency","volume":"169","author":"Boussofara","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0061","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.anai.2015.04.013","article-title":"Multiple necrotic deep wound infections associated with a subcutaneous immunoglobulin infusion","volume":"115","author":"Abraham","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0062","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.anai.2018.09.308","article-title":"A novel gene mutation associated with common variable immunodeficiency and pyoderma","volume":"121","author":"Joseph","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0063","first-page":"129","article-title":"Pyoderma gangrenosum with common variable immunodeficiency","volume":"27","author":"Simsek","year":"2015","journal-title":"Wounds Compend Clin Res Pract"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0064","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdcr.2021.10.015","article-title":"A novel NFkB1 mutation linking pyoderma gangrenosum and common variable immunodeficiency","volume":"18","author":"Sun","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.673453","article-title":"Case report: a novel mutation in nfkb1 associated with pyoderma gangrenosum","volume":"12","author":"Fang","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104144","article-title":"Recurrent necrotizing cellulitis, multi-organ autoimmune disease and humoral immunodeficiency due to a novel NFKB1 frameshift mutation","volume":"64","author":"Bergbreiter","year":"2021","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0067","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","article-title":"Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes","volume":"140","author":"Kaustio","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0068","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0069","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangrenosum \u2013 a review","volume":"2","author":"Wollina","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mpdhp.2020.10.011","article-title":"Non-infectious neutrophilic and pustular dermatoses","volume":"27","author":"M\u00f6ckel","year":"2021","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0071","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum a comparison of typical and atypical forms with an emphasis on time to remission. case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0072","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/wound.2020.1168","article-title":"A wound care specialist\u2019s approach to pyoderma gangrenosum","volume":"9","author":"Croitoru","year":"2020","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0073","first-page":"290","article-title":"Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials","volume":"179","author":"Partridge","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0074","first-page":"1059","article-title":"Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone","volume":"10","author":"Handler","year":"2011","journal-title":"J Drugs Dermatol JDD"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0075","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jaad.2017.11.063","article-title":"Neutrophilic dermatoses: Pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses","volume":"79","author":"Ashchyan","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0076","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"The BMJ"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0077","article-title":"Neutrophilic and eosinophilic dermatoses associated with hematological malignancy","volume":"10","author":"Maronese","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0078","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archderm.1982.01650160053024","article-title":"Neutrophilic eccrine hidradenitis: a distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy","volume":"118","author":"Harrist","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0079","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.abd.2022.08.005","article-title":"Dermatological manifestations of hematologic neoplasms. Part II: nonspecific skin lesions\/paraneoplastic diseases","volume":"98","author":"de Souza","year":"2023","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.blre.2017.07.003","article-title":"The skin as a window to the blood: cutaneous manifestations of myeloid malignancies","volume":"31","author":"Li","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0081","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-4362.2001.11775.x","article-title":"Neutrophilic eccrine hidradenitis unassociated with chemotherapy in a patient with acute myelogenous leukemia","volume":"40","author":"Roustan","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0082","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.1993.01680270135026","article-title":"Neutrophilic eccrine hidradenitis heralding the onset of acute myelogenous leukemia","volume":"129","author":"Pierson","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0083","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0190-9622(96)90092-4","article-title":"Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis","volume":"35","author":"Shear","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0084","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archderm.1986.01660190087022","article-title":"Neutrophilic eccrine hidradenitis associated with hodgkin\u2019s disease and chemotherapy: a case report","volume":"122","author":"Beutner","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1525-1470.1989.tb00264.x","article-title":"Neutrophilic eccrine hidradenitis: a case report and review of the literature","volume":"6","author":"Bailey","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0086","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2230.1989.tb02580.x","article-title":"Neutrophilic eccrine hidradenitis\u2014a report of two additional cases","volume":"14","author":"Cogolludo","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0087","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1097-0142(19881215)62:12<2532::AID-CNCR2820621214>3.0.CO;2-D","article-title":"Neutrophilic eccrine hidradenitis: evidence implicating bleomycin as a causative agent","volume":"62","author":"Scallan","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0088","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-0560.1987.tb00499.x","article-title":"Neutrophilic eccrine hidradenitis associated with induction chemotherapy","volume":"14","author":"Fitzpatrick","year":"1987","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0089","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.9114","article-title":"Neutrophilic eccrine hidradenitis from granulocyte-stimulating factor in a patient with ANCA vasculitis","volume":"12","author":"Chaisrimaneepan","year":"2024","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5826\/dpc.0603a11","article-title":"Two neutrophilic dermatoses captured simultaneously on histology","volume":"6","author":"Wlodek","year":"2016","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0091","unstructured":"Subcorneal pustular dermatosis (Sneddon-Wilkinson disease). DermNet\u00ae. https:\/\/dermnetnz.org\/topics\/subcorneal-pustular-dermatosis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0092","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijwd.2020.02.003","article-title":"Subcorneal pustular dermatosis: Comprehensive review and report of a case presenting during pregnancy","volume":"6","author":"Bhargava","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0093","article-title":"Subcorneal pustular dermatosis in childhood: a case report and review of the literature","volume":"2013","author":"Scalvenzi","year":"2013","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0094","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000018224","article-title":"Successful treatment of subcorneal pustular ermatosis (Sneddon-Wilkinson disease) by acitretin: report of a case","volume":"199","author":"Marli\u00e8re","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2230.2008.02706.x","article-title":"Subcorneal pustular dermatosis: 50 years on","volume":"33","author":"Cheng","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0096","first-page":"124","article-title":"Subcorneal pustular dermatosis and IgA myeloma","volume":"187","author":"Atukorala","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0097","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0190-9622(98)70093-3","article-title":"Subcorneal pustular dermatosis in a patient with aplastic anemia","volume":"39","author":"Park","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0098","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D336N564F4","article-title":"Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) occurring in association with nodal marginal zone lymphoma: a case report","volume":"14","author":"Ratnarathorn","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0099","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0738-081X(99)00127-3","article-title":"Neutrophilic dermatoses associated with hematologic disorders","volume":"18","author":"Hensley","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/00015550310016661","article-title":"Subcorneal pustular dermatosis in association with chronic lymphocytic leukaemia","volume":"83","author":"Brown","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0101","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4103\/idoj.idoj_706_22","article-title":"Subcorneal pustular dermatosis occuring in association with pyoderma gangrenosum and rheumatoid arthritis: a triple whammy!","volume":"14","author":"Khurana","year":"2023","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2133.1991.tb14179.x","article-title":"Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA","volume":"125","author":"Todd","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.mcna.2021.04.011","article-title":"Recognition and Management of Cutaneous Connective Tissue Diseases","volume":"105","author":"Kus","year":"2021","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0104","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780390103","article-title":"Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium","volume":"39","author":"Belmont","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0105","article-title":"Cutaneous vasculitis; An algorithmic approach to diagnosis","volume":"9","author":"Alpsoy","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0106","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40257-014-0076-6","article-title":"A practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0107","article-title":"Associated pyoderma gangrenosum, erythema elevatum diutinum, and chronic recurrent annular dermatosis: the neutrophilic disease spectrum","volume":"14","author":"Salih Alj","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0108","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3889\/oamjms.2019.765","article-title":"Erythema elevatum diutinum - two case reports, two different clinical presentations, and a short literature review","volume":"7","author":"Wollina","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0109","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0738-081X(99)00120-0","article-title":"Erythema elevatum diutinum","volume":"18","author":"Gibson","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_sbref0110","series-title":"StatPearls","article-title":"Erythema elevatum diutinum","author":"Newburger","year":"2024"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0111","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijd.IJD_219_19","article-title":"Erythema elevatum diutinum: revisiting a rare entity in pediatric age group","volume":"66","author":"Kalekhan","year":"2021","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0112","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/jdv.12566","article-title":"Erythema elevatum diutinum: a review of presentation and treatment","volume":"28","author":"Momen","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0113","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0378-6323.107646","article-title":"Erythema elevatum diutinum","volume":"79","author":"Sharma","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0114","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40257-020-00553-9","article-title":"Immune- mediated dermatoses in patients with haematological malignancies: a comprehensive review","volume":"21","author":"Maglie","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0115","series-title":"Hurwitz Clinical Pediatric Dermatology (Fifth Edition)","first-page":"495","article-title":"21 - Vasculitic disorders","author":"Paller","year":"2016"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0116","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archderm.1980.01640300081025","article-title":"Erythema elevatum diutinum treated with niacinamide and tetracycline","volume":"116","author":"Kohler","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0117","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.1989.tb02611.x","article-title":"Erythema elevatum diutinum-a case successfully treated with colchicine","volume":"14","author":"Henriksson","year":"1989","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2230.1992.tb00171.x","article-title":"Erythema elevatum diutinum: a clinicopathological study","volume":"17","author":"Wilkinson","year":"1992","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0119","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/archderm.1996.03890350102016","article-title":"Erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with intermittent plasma exchange","volume":"132","author":"Chow","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/abd1806-4841.20177359","article-title":"Beh\u00e7et\u2019s disease: review with emphasis on dermatological aspects","volume":"92","author":"Scherrer","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_sbref0121","series-title":"StatPearls","article-title":"Behcet disease","author":"Adil","year":"2024"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190182","article-title":"Cancer risk in Korean patients with Beh\u00e7et\u2019s disease: a nationwide population-based study","volume":"12","author":"Jung","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0123","unstructured":"Behcet Disease Images \u2014 DermNet. DermNet\u00ae. October 26, 2023. Accessed August 20, 2024. https:\/\/dermnetnz.org\/images\/behcet-disease-images"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0124","first-page":"1209","article-title":"Cancer incidence in Beh\u00e7et\u2019s disease","volume":"189","author":"Guven","year":"2020","journal-title":"Ir J Med Sci 1971 -"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3899\/jrheum.140770","article-title":"Risk of overall and site-specific cancers in beh\u00e7et disease: a nationwide population-based study in Taiwan","volume":"42","author":"Wang","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0126","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2017.09.035","article-title":"Cancer risk in patients with Beh\u00e7et disease: a nationwide population-based dynamic cohort study from Korea","volume":"78","author":"Na","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0127","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1756-185X.12269","article-title":"Behcet\u2019s disease associated with malignancy: a report of 41 Chinese cases","volume":"17","author":"Lin","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0128","unstructured":"Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2016: Beh\u00e7et\u2019s syndrome. Clin Exp Rheumatol. Accessed August 20, 2024. https:\/\/www.clinexprheumatol.org\/abstract.asp?a=10952."},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0129","article-title":"Mucocutaneous manifestations of Beh\u00e7et\u2019s disease","volume":"7","author":"Nakamura","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0130","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00b8cet disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0131","first-page":"24","article-title":"General manifestations of Beh\u00e7et\u2019s syndrome and the success of CO2-laser as treatment for oral lesions: a review of the literature and case presentation","volume":"58","author":"Demetriades","year":"2009","journal-title":"J Mass Dent Soc"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0132","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000182257","article-title":"Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Beh\u00e7ets disease","volume":"218","author":"K\u00f6se","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0133","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1756-185X.2010.01531.x","article-title":"Pimecrolimus versus placebo in genital aphthous ulcers of Behcet\u2019s disease: a randomized double-blind controlled trial","volume":"13","author":"Chams-Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0134","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2230.2011.04169.x","article-title":"Refractory aphthous ulceration treated with thalidomide: a report of 10 years\u2019 clinical experience","volume":"37","author":"Cheng","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjoto.2014.04.014","article-title":"Infliximab for refractory oral ulcers","volume":"35","author":"Ryu","year":"2014","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0136","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3899\/jrheum.141344","article-title":"Alemtuzumab as remission induction therapy in Beh\u00e7et disease: a 20-year experience","volume":"42","author":"Mohammad","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0137","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10067-013-2443-8","article-title":"Anakinra treatment in drug-resistant Behcet\u2019s disease: a case series","volume":"34","author":"Cantarini","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0138","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-015-3004-0","article-title":"Efficacy and safety profile of anti-interleukin-1 treatment in Beh\u00e7et\u2019s disease: a multicenter retrospective study","volume":"35","author":"Emmi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0139","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u00e7et\u2019s syndrome \u2014 a phase 2, placebo-controlled study","volume":"372","author":"Hatemi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0140","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/ijd.12144","article-title":"Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Beh\u00e7et\u2019s disease","volume":"52","author":"Mumcu","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000358125","article-title":"Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Beh\u00e7et\u2019s disease: a case series","volume":"228","author":"Vitale","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0142","first-page":"e68","article-title":"The therapeutic role of isotretinoin in the management of Beh\u00e7et\u2019s disease: a single-blinded, controlled therapeutic study","volume":"12","author":"Sharquie","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0143","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2017.05.002","article-title":"Ustekinumab for Beh\u00e7et\u2019s disease","volume":"82","author":"Mirouse","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0144","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0043-1770958","article-title":"VEXAS syndrome\u2014Review","volume":"10","author":"Zhang","year":"2023","journal-title":"Glob Med Genet"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0145","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0146","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.3390\/jcm10235586","article-title":"USAID Associated with myeloid neoplasm and VEXAS syndrome: two differential diagnoses of suspected adult onset still\u2019s disease in elderly patients","volume":"10","author":"Delplanque","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0147","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11739-023-03193-z","article-title":"VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases","volume":"18","author":"Vitale","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0148","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in VEXAS syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0149","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1182\/bloodadvances.2023010814","article-title":"Intrapatient competition of VEXAS syndrome and CML clones","volume":"7","author":"Djerbi","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5114\/reum\/163090","article-title":"VEXAS syndrome: a new discovered systemic rheumatic disorder","volume":"61","author":"Kucharz","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0151","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","article-title":"An update on VEXAS syndrome","volume":"19","author":"Al-Hakim","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0152","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100242","article-title":"VEXAS syndrome\u2014 diagnostic clues for the dermatologist and gaps in our current understanding: a narrative review","volume":"4","author":"Nicholson","year":"2024","journal-title":"JID Innov"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0153","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0154","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS","volume":"149","author":"Van Der Made","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0155","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1111\/jdv.17924","article-title":"The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico-histopathologic presentation","volume":"36","author":"Khosravi-Hafshejani","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0156","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.2020010286","article-title":"Novel somatic mutations in UBA1 as a cause of VEXAS syndrome","volume":"137","author":"Poulter","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0157","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0158","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0159","article-title":"The VEXAS syndrome: uncontrolled inflammation and macrocytic anaemia in a 77-year-old male patient","volume":"8","author":"Himmelmann","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0160","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1093\/rheumatology\/keab225","article-title":"VEXAS syndrome: still expanding the clinical phenotype","volume":"60","author":"Oganesyan","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0161","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/diagnostics12071590","article-title":"VEXAS Syndrome: A novelty in MDS landscape","volume":"12","author":"Templ\u00e9","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0162","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0163","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jdcr.2017.12.012","article-title":"Schnitzler syndrome associated with hairy cell leukemia presenting with chronic urticaria and arthralgias","volume":"4","author":"Fank","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0164","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/bjh.17930","article-title":"Towards treatments for VEXAS","volume":"196","author":"Patel","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0165","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","article-title":"Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan","volume":"80","author":"Kirino","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0166","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000661","article-title":"Azacytidine treatment for VEXAS syndrome","volume":"5","author":"Raaijmakers","year":"2021","journal-title":"HemaSphere"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0167","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.mayocp.2021.06.006","article-title":"Clinical heterogeneity of the VEXAS syndrome: a case series","volume":"96","author":"Koster","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0168","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/art.41775","article-title":"Extensive Multiple Organ Involvement in VEXAS Syndrome","volume":"73","author":"Takahashi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0169","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdcr.2021.06.010","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome\u2014clinical presentation of a newly described somatic, autoinflammatory syndrome","volume":"14","author":"Alhomida","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/biom14060646","article-title":"Schnitzler syndrome: insights into its pathogenesis, clinical manifestations, and current management","volume":"14","author":"Braud","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/2045-7022-4-41","article-title":"Schnitzler\u2019s syndrome: lessons from 281 cases","volume":"4","author":"de Koning","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0172","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaad.2012.04.027","article-title":"Clinical and histopathologic review of Schnitzler syndrome: the Mayo Clinic experience (1972-2011)","volume":"67","author":"Sokumbi","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0173","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MD.0b013e3181943f5e","article-title":"Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. report of 9 new cases and review of the literature","volume":"88","author":"Kieffer","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0174","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jdcr.2019.07.026","article-title":"Eosinophilic dermatosis of hematologic malignancy responding to dupilumab in a patient with chronic lymphocytic leukemia","volume":"5","author":"Jin","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0175","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jaci.2016.07.041","article-title":"Efficacy and safety of canakinumab in Schnitzler syndrome: A multicenter randomized placebo-controlled study","volume":"139","author":"Krause","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0176","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaci.2019.12.909","article-title":"Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome","volume":"145","author":"Krause","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0177","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2012.02843.x","article-title":"Efficacy and safety of the interleukin-1 antagonist rilonacept in S chnitzler syndrome: an open-label study","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0178","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1600-0560.2012.01906.x","article-title":"Eosinophilic dermatosis of hematologic malignancy","volume":"39","author":"Farber","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0179","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaad.2018.11.048","article-title":"Eosinophilic dermatosis of hematologic malignancy: a retrospective cohort of 37 patients from an Italian center","volume":"81","author":"Grandi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0180","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12015","article-title":"Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group","volume":"89","author":"Bairey","year":"2012","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0181","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V26.3.257.257","article-title":"Exaggerated delayed hypersensitivity to mosquito bites in chronic lymphocytic leukemia","volume":"26","author":"Weed","year":"1965","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0182","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0190-9622(98)70398-6","article-title":"Exaggerated arthropod-bite lesions in patients with chronic lymphocytic leukemia: a clinical, histopathologic, and immunopathologic study of eight patients","volume":"39","author":"Davis","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0183","article-title":"Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia\/non-Hodgkin\u2019s B lymphoma: a single center prospective clinico-pathological study","volume":"10","author":"Michelerio","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0184","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/archderm.135.12.1503","article-title":"Insect bite\u2013like reaction in patients with hematologic malignant neoplasms","volume":"135","author":"Barzilai","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0185","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-4632.2004.02145.x","article-title":"Insect bite-like reaction associated with mantle cell lymphoma: a report of two cases and review of the literature","volume":"43","author":"Dodiuk-Gad","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0186","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/jdv.14805","article-title":"T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity","volume":"32","author":"Visseaux","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0187","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jdv.12652","article-title":"Chronic relapsing eosinophilic cellulitis associated, although independent in severity, with chronic lymphocytic leukemia","volume":"30","author":"Shin","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0188","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1742-1241.2004.00116.x","article-title":"An itchy vesiculobullous eruption in a patient with chronic lymphocytic leukaemia","volume":"58","author":"Cocuroccia","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0189","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2007.00372.x","article-title":"Exaggerated insect bite reaction exacerbated by a pyogenic infection in a patient with chronic lymphocytic leukaemia","volume":"48","author":"Walker","year":"2007","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/ijd.ijd_847_21","article-title":"Haematologic-related malignancy-induced eosinophilic dermatoses (he remained): a narrative review","volume":"67","author":"Kar","year":"2022","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0191","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0190-9622(86)70254-5","article-title":"A characteristic vesiculobullous eruption in patients with chronic lymphocytic leukemia","volume":"15","author":"Rosen","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0192","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/120347540100500406","article-title":"Arthropod bites manifesting as recurrent bullae in a patient with chronic lymphocytic leukemia","volume":"5","author":"Blum","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0193","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cup.13389","article-title":"Eosinophilic dermatosis of hematologic malignancy: Correlation of molecular characteristics of skin lesions and extracutaneous manifestations of hematologic malignancy","volume":"46","author":"Meiss","year":"2019","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0194","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/ijd.13807","article-title":"Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge","volume":"56","author":"Maglie","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0195","article-title":"A case of eosinophilic dermatosis of hematologic malignancy treated with narrow-band ultraviolet B (NBUVB)","volume":"15","author":"Pan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0196","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.jaad.2019.08.061","article-title":"Response to: \u201cHematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): an eosinophilic dermatosis predominantly associated with chronic lymphocytic leukemia","volume":"82","author":"Maglie","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0197","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14206","article-title":"Eosinophilic dermatosis of hematologic malignancy effectively controlled with omalizumab maintenance therapy","volume":"33","author":"Lor","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0198","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13725","article-title":"Targeted inhibition of IL-4\/13 with dupilumab is an effective treatment for eosinophilic dermatosis of hematologic malignancy","volume":"33","author":"Goyal","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0199","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jdv.14199","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome) \u2013 a systematic review on risk factors, diagnosis, prognosis and management","volume":"31","author":"R\u00e4\u00dfler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0200","article-title":"Bazex syndrome (acrokeratosis paraneoplastica): a narrative review of pathogenesis, clinical manifestations, and therapeutic approaches","volume":"15","author":"Shah","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0201","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D34FZ6F008","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature","volume":"12","author":"Sharma","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0202","first-page":"1","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome): report of a case associated with small cell lung carcinoma and review of the literature","volume":"5","author":"Zarzour","year":"2011","journal-title":"J Radiol Case Rep"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0203","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/0145561317096010-1119","article-title":"Acrokeratosis paraneoplastica (Bazex syndrome)","volume":"96","author":"Lechien","year":"2017","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.clindermatol.2026.07.026_bib0204","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0190-9622(87)80057-9","article-title":"Acrokeratosis paraneoplastica (Bazex\u2019 syndrome)","volume":"16","author":"Richard","year":"1987","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X26002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X26002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:55:08Z","timestamp":1791568508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X26002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":204,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0738081X26002063"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.07.026","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophilic dermatoses","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}